Marshall Wace, LLP Repligen Corp Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Repligen Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 360,687 shares of RGEN stock, worth $45.5 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
360,687
Previous 320,777
12.44%
Holding current value
$45.5 Million
Previous $57.7 Million
15.02%
% of portfolio
0.1%
Previous 0.1%
Shares
22 transactions
Others Institutions Holding RGEN
# of Institutions
522Shares Held
53.2MCall Options Held
1.05MPut Options Held
228K-
Black Rock Inc. New York, NY7.77MShares$980 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$643 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.57MShares$450 Million0.08% of portfolio
-
State Street Corp Boston, MA1.76MShares$222 Million0.01% of portfolio
-
Macquarie Group LTD Australia, C31.46MShares$185 Million0.31% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....